The Kenya Ministry of Health, together with TB Alliance and other partners launched the child-friendly tuberculosis (TB) medicines in Nairobi on Tuesday, making Kenya the first country in the world to roll out these products nationally.
The improved medicines are easier for caregivers to give and for children to take, and are expected to help improve treatment and child survival from TB.
Tuberculosis is a major killer of children. According to the Ministry of Health, in 2015, Kenya reported nearly 7,000 cases of TB in infants and children, with those under the age of five at greatest risk of having severe forms of TB and dying from the disease.
The World Health Organisation (WHO), records that at least one million children suffer from TB each year and 140,000 children die of this curable and preventable disease globally.
“Kenya is playing a leading role in the fight against childhood TB by being the first to introduce improved TB medicines for children,” said Kenya’s Cabinet Secretary for Health, Dr Cleopa Mailu.
“Now, with the appropriate treatments, we can make rapid progress in finding and treating children with TB so we can achieve a TB-free generation,” said Dr Mailu in a statement.
According to caregivers at the launch, they previously, had to cut or crush multiple, bitter-tasting pills in an attempt to achieve the right doses for children. This made the six-month treatment journey difficult for children and their families, contributing to treatment failure and death from the disease.
The treatments now being introduced are the first to meet the WHO’s guidelines for childhood TB treatment. The Health Ministry said the drugs were not new but rather improved formulations that came in the correct doses and required fewer pills, were flavoured and dissolved in water.
The development of the medicines was overseen by TB Alliance, an international not-for-profit organisation, and was funded by UNITAID and other partners.
UNITAID is an international drug purchasing facility that provides medicine and treatment against HIV/AIDS, malaria and tuberculosis for the poor.
“These new treatments won’t have an impact until they reach the children that need them,” said Dr Cherise Scott, Director of Pediatric Programs, TB Alliance.
“We are proud to partner with the Government of Kenya, the first of many countries, as they work to translate the potential of these medicines into lives saved.
“No child should die of TB, yet for too long, we have not had the medicines to mount a sustainable response against childhood TB,” said Robert Matiru, Director of Operations for UNITAID.
“UNITAID’s investment in addressing this problem should help equip countries, healthcare workers, and families with the tools they need to rise to the challenge.”
Starting October 1, 2016, all children in Kenya who will be initiated on TB treatment will be given the improved formulation.
“Childhood TB is a problem that can be solved when we choose to act,” said Dr Enos Masini, Head of Kenya’s National Tuberculosis, Leprosy and Lung Disease Program.
Children often get TB from infected persons in their environment. This can be at home, at school or in any other place where children spend their time. Children should be taken to the nearest health facility to receive a TB diagnosis if they have a cough, fever, night sweats, reduced playfulness, or if they fail to gain weight.
The health ministry advised that if one member of a household was diagnosed with TB, all other household members should be tested for TB, especially children. TB testing and treatment is free at all public health facilities in Kenya.
--ANA--
